13F filer · CIK 1697748 ↗
ARK Invest
You are looking at Q2 2022. See the latest, Q2 2026 →
Reported value
$16.91B
−29% on the quarter before
Positions
354
11 new · 10 sold out
Top 10
46.2%
of the value
Est. gain
−$7.14B
on stocks held all quarter
Est. return
−32.1%
on those stocks since Q1 2022
Positions as of Jun 30, 2022, from ARK Invest's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2022. Striped tiles are options.
Largest buys
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Draftkings Inc~$342.5MNew · 0.0% → 2.0%+25,275,813 shares
- Roku Inc~$177.8MAdded · 4.3% → 5.7%+1,873,368 shares
- Coinbase~$153.7MAdded · 5.5% → 4.1%+1,968,476 shares
- Nvidia~$126.1MAdded · 0.0% → 0.7%+675,233 shares
- Zoom~$124.8MAdded · 4.1% → 6.1%+1,161,839 shares
- Shopify Inc~$116.4MAdded · 2.5% → 2.7%+310,423 shares
- Block~$72.6MAdded · 4.7% → 4.7%+829,086 shares
- Ginkgo Bioworks Holdings Inc~$70.3MAdded · 1.1% → 1.6%+22,824,417 shares
- UiPath~$68.2MAdded · 3.0% → 3.8%+3,994,297 shares
- Somalogic IncCALL~$62.0MNew · 0.0% → 0.4%+10,333,075 underlying
Largest sells
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Spotify Technology Sa~$264.4MCut · 2.8% → 1.4%−2,344,963 shares
- Sea~$145.6MCut · 1.3% → 0.4%−1,761,480 shares
- Tesla~$114.4MCut · 7.2% → 6.5%−150,889 shares
- Somalogic Inc~$83.3MSold out · 0.3% → 0.0%−10,390,335 shares
- Ionis Pharmaceuticals Inc~$53.7MCut · 1.0% → 1.0%−1,470,011 shares
- Twitter Inc~$52.4MCut · 0.2% → 0.0%−1,331,779 shares
- Baidu~$24.8MCut · 0.1% → 0.0%−177,042 shares
- Vertex Pharmaceuticals Inc~$15.1MCut · 0.5% → 0.6%−56,253 shares
- Lendingclub Corp~$14.7MCut · 0.1% → 0.0%−940,747 shares
- Trimble~$13.1MCut · 0.7% → 0.8%−192,503 shares
Holdings
As of Jun 30, 2022. Changes are in shares against Mar 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TeslaCommon Stock · shares −9.5% · price −29.6% | 6.5% | $1.09B | −$461.0M | ||||||||
| ZoomCommon Stock · shares +14% · price −8.3% | 6.1% | $1.03B | −$82.3M | ||||||||
| Roku IncCommon Stock · shares +23% · price −24.2% | 5.7% | $962.7M | −$251.2M | ||||||||
| BlockCommon Stock · shares +10.0% · price −35.5% | 4.7% | $799.5M | −$399.5M | ||||||||
| Exact Sciences CorpCommon Stock · shares +4.5% · price −28.8% | 4.4% | $745.7M | −$288.1M | ||||||||
| CoinbaseCommon Stock · shares +28% · price −58.9% | 4.1% | $699.1M | −$780.4M | ||||||||
| Teladoc Health IncCommon Stock · shares +4.2% · price −52.7% | 4.1% | $691.8M | −$740.5M | ||||||||
| UiPathCommon Stock · shares +12% · price −20.9% | 3.8% | $641.8M | −$151.9M | ||||||||
| TwilioCommon Stock · shares +11% · price −36.2% | 3.5% | $586.1M | −$299.5M | ||||||||
| Crispr Therapeutics AgCommon Stock · shares +3.4% · price −7.5% | 3.3% | $564.7M | −$44.4M | ||||||||
| Shopify IncCommon Stock · shares +34% · price −44.5% | 2.7% | $455.2M | −$271.7M | ||||||||
| Intellia Therapeutics IncCommon Stock · shares +5.9% · price −36.5% | 2.6% | $439.0M | −$238.3M | ||||||||
| Unity Software IncCommon Stock · shares +11% · price −59.7% | 2.2% | $366.8M | −$488.4M | ||||||||
| Draftkings IncCommon Stock · shares New | 2.0% | $342.5M | — | ||||||||
| RobinhoodCommon Stock · shares +11% · price −25.5% | 2.0% | $337.6M | −$104.7M | ||||||||
| Beam Therapeutics IncCommon Stock · shares +7.2% · price −38.6% | 1.8% | $309.3M | −$181.4M | ||||||||
| Signify Health IncCommon Stock · shares +4.2% · price −24.9% | 1.8% | $298.3M | −$94.9M | ||||||||
| Ginkgo Bioworks Holdings IncCommon Stock · shares +35% · price −23.6% | 1.6% | $269.1M | −$61.3M | ||||||||
| Pagerduty IncCommon Stock · shares +6.0% · price −27.9% | 1.6% | $268.3M | −$98.0M | ||||||||
| Fate Therapeutics IncCommon Stock · shares +4.4% · price −40.4% | 1.6% | $265.0M | −$172.2M | ||||||||
| Spotify Technology SaCommon Stock · shares −53% · price −25.3% | 1.4% | $230.4M | −$78.2M | ||||||||
| RobloxCommon Stock · shares +22% · price −35.3% | 1.3% | $221.7M | −$99.3M | ||||||||
| Twist Bioscience CorpCommon Stock · shares +19% · price −31.1% | 1.3% | $213.4M | −$80.8M | ||||||||
| 10x Genomics IncCommon Stock · shares +6.2% · price −32.7% | 1.1% | $184.5M | −$84.4M | ||||||||
| Ionis Pharmaceuticals IncCommon Stock · shares −24% · price −1.4% | 1.0% | $171.7M | −$2.4M | ||||||||
| Total · 354 positions | 100% | $16.91B | −$7.14B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2022 to Q2 2022: 328 stocks held throughout, down $7.14B (−32.1%).
- Byd Co Ltd+$7.0M+28%
- Vertex Pharmaceuticals Inc+$2.8M+3%
- Komatsu Ltd+$1.8M+3%
- Pfizer Inc+$931,918+2%
- Innoviz Technologies Ltd+$854,005+35%
- Block−$399.5M−35%
- Tesla−$461.0M−30%
- Unity Software Inc−$488.4M−60%
- Teladoc Health Inc−$740.5M−53%
- Coinbase−$780.4M−59%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $15.40B+20% | SEC ↗ |
| Q1 2026 | May 12, 2026 | $12.86B−15% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $15.07B−10% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $16.80B+23% | SEC ↗ |
| Q2 2025 | Jul 30, 2025 | $13.64B+37% | SEC ↗ |
| Q1 2025 | May 7, 2025 | $9.99B−17% | SEC ↗ |
| Q4 2024 | Feb 4, 2025 | $12.01B+10% | SEC ↗ |
| Q3 2024 | Oct 31, 2024 | $10.93B−3% | SEC ↗ |
| Q2 2024 | Jul 26, 2024 | $11.27B−22% | SEC ↗ |
| Q1 2024 | Apr 18, 2024 | $14.44B−14% | SEC ↗ |
| Q4 2023 | Jan 17, 2024 | $16.89B+29% | SEC ↗ |
| Q3 2023 | Oct 18, 2023 | $13.07B−13% | SEC ↗ |
| Q2 2023 | Jul 10, 2023 | $15.10B+4% | SEC ↗ |
| Q1 2023 | Apr 17, 2023 | $14.55B+26% | SEC ↗ |
| Q4 2022 | Jan 24, 2023 | $11.54B−20% | SEC ↗ |
| Q3 2022 | Oct 17, 2022 | $14.35B−15% | SEC ↗ |
| Q2 2022 | Jul 11, 2022 | $16.91B−29% | SEC ↗ |
| Q1 2022 | Apr 18, 2022 | $23.96B−28% | SEC ↗ |
| Q4 2021 | Jan 28, 2022 | $33.08B−21% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $41.64B−23% | SEC ↗ |
| Q2 2021 | Aug 5, 2021 | $53.74B+7% | SEC ↗ |
| Q1 2021 | May 13, 2021 | $50.34B+34% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $37.59B+123% | SEC ↗ |
| Q3 2020 | Oct 30, 2020 | $16.86B+81% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $9.30B+132% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $4.01B+1% | SEC ↗ |
| Q4 2019 | Jan 31, 2020 | $3.96B−13% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $4.58B+15% | SEC ↗ |
| Q2 2019 | Jul 30, 2019 | $3.97B+13% | SEC ↗ |
| Q1 2019 | May 13, 2019 | $3.50B+42% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 (amended) | $2.46B−26% | SEC ↗ |
| Q3 2018 | Nov 7, 2018 | $3.31B+21% | SEC ↗ |
| Q2 2018 | Aug 7, 2018 | $2.73B+36% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $2.01B+60% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $1.26B+53% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $819.3M+60% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $513.6M+48% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $346.9M+26% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 | $274.9M | SEC ↗ |